Research output per year
Research output per year
Search results
-
2019
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
OPTIMISMM trial investigators, 1 Jun 2019, In: The Lancet Oncology. 20, 6, p. 781-794 14 p.Research output: Contribution to journal › Article › peer-review
282 Citations (Scopus) -
2012
Fluorescence-based experimental model to evaluate the concomitant effect of drugs on the tumour microenvironment and cancer cells
Ramasamy, K., Khatun, H., Macpherson, L., Caley, M. P., Sturge, J., Mufti, G. J., Schey, S. A. & Calle, Y., Jun 2012, In: British Journal of Haematology. 157, 5, p. 564-579 16 p.Research output: Contribution to journal › Article › peer-review
16 Citations (Scopus) -
2011
Alemtuzumab-Based Reduced-Intensity Conditioning Allogeneic Transplantation for Myeloma and Plasma Cell Leukemia - A Single-Institution Experience
Ramasamy, K., Mahmood, S., Lim, Z., Corderoy, S., Devereux, S., Mufti, G. J., Pagliuca, A. & Schey, S., Apr 2011, In: Clinical Lymphoma Myeloma & Leukemia. 11, 2, p. 242 - 245 4 p.Research output: Contribution to journal › Article › peer-review
4 Citations (Scopus)